Clinical Trial Update: Continuing Treatment With Pegasys and Copegus [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating Pegasys (peginterferon alfa-2a) and Copegus (ribavirin) for chronic hepatitis C, with the current status listed as UNKNO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Májbetegekért Alapítvány | Conditions: Chronic Hepatitis C | Phase 3 | Status: UNKNOWN